Showing results (741-750 of 2,282) with videos related to

Sort By:
Pageof 229
HIV Medicine|February 28, 2009
Poly-l-lactic acid for HIV-1 facial lipoatrophy: 48-week follow-upD Carey, D Baker, K Petoumenos, et al.
HIV Medicine|January 31, 2009
How does loss to follow-up influence cohort findings on HIV infection? A joint analysis of the French hospital database on HIV, Mortalité 2000 survey and death certificatesE Lanoy, C Lewden, L Lièvre, et al.
HIV Medicine|January 31, 2009
Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutationsJ Audsley, N Arrifin, L K W Yuen, et al.
HIV Medicine|August 8, 2009
High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapyC Laurent, A Bourgeois, E Mpoudi-Ngolé, et al.
HIV Medicine|September 8, 2009
Prevalence of etravirine mutations and impact on response to treatment in routine clinical care: the Swiss HIV Cohort Study (SHCS)A U Scherrer, B Hasse, V von Wyl, et al.
HIV Medicine|September 8, 2009
Discordant responses on starting highly active antiretroviral therapy: suboptimal CD4 increases despite early viral suppression in the UK Collaborative HIV Cohort (UK CHIC) StudyR J C Gilson, S-L Man, A Copas, et al.
HIV Medicine|September 16, 2009
Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkersAmy C Justice, K A McGinnis, M Skanderson, et al.
HIV Medicine|September 29, 2009
Risk factors for HIV transmission among heterosexual discordant couples in South IndiaN Kumarasamy, K K Venkatesh, A K Srikrishnan, et al.
HIV Medicine|September 30, 2009
The relationship between antiretroviral prescription patterns and treatment guidelines in treatment-naïve HIV-1-infected patientsI Suarez-Lozano, P Viciana, J-R Lacalle, et al.
HIV Medicine|August 26, 2009
Risk factors for and clinical characteristics of severe hyperlactataemia in patients receiving antiretroviral therapy: a case-control studyMeg Osler, D Stead, K Rebe, et al.
Pageof 229